Exploration of Targeted Anti-tumor Therapy : Impact Factor & More
eISSN: 2692-3114
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Exploration of Targeted Anti-tumor Therapy
Exploration of Targeted Anti-tumor Therapy Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Open Exploration Publishing Inc. |
| Language | English |
| Publication Time | 13 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 13 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Exploration of Targeted Anti-tumor Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Exploration of Targeted Anti-tumor Therapy
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities
- 6 Nov 2025
- Exploration of Targeted Anti-tumor Therapy
Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations
- 2 Nov 2025
- Exploration of Targeted Anti-tumor Therapy
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
- 28 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
Retraction: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
- 28 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
New approaches of green silver nanoparticles for cancer and biomedical applications: a review
- 23 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic nanoparticles for the treatment of colorectal cancer
- 20 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities
- 6 Nov 2025
- Exploration of Targeted Anti-tumor Therapy
Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations
- 2 Nov 2025
- Exploration of Targeted Anti-tumor Therapy
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
- 28 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
Retraction: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
- 28 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
New approaches of green silver nanoparticles for cancer and biomedical applications: a review
- 23 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic nanoparticles for the treatment of colorectal cancer
- 20 Oct 2025
- Exploration of Targeted Anti-tumor Therapy
FAQs on Exploration of Targeted Anti-tumor Therapy
How many articles did Exploration of Targeted Anti-tumor Therapy publish last year? 
Who is the publisher of Exploration of Targeted Anti-tumor Therapy?
